Smartwise Sweden AB

Clinical research in unresectable locally advanced pancreatic cancer with a focus on treatment delivery in a difficult-to-access tumour setting.

• Locally advanced pancreatic malignancy
• Unresectable disease
• Peri-tumoral therapy delivery

The sponsor’s activity is centred on interventions relevant to pancreatic oncology, particularly approaches intended to support drug administration in patients whose disease cannot be surgically removed.